For Clinicians

Actionable F2+ triage at the point of care.

Outcomes · Clinician

What LiverTwin™ means for clinicians

LiverTwin delivers structured, actionable triage signals at the point of care — surfacing F2+ patients from routine lab and imaging data so hepatologists and primary-care providers can act earlier, prioritise confidently, and reduce unnecessary advanced diagnostics. The platform integrates into existing EHR workflows, presenting risk scores alongside guideline-anchored next steps without disrupting clinical rhythm.

Efficiency

Faster triage

Automated FIB-4 + NIT aggregation cuts manual chart review from minutes to seconds per patient.

Confidence

Evidence-backed decisions

Every recommendation is traceable to AASLD/EASL guidelines, giving clinicians a defensible audit trail.

Integration

EHR-native workflow

Outputs surface inside existing clinical interfaces — no new portal, no duplicate data entry, no workflow disruption.

For Hepatologists · PCPs · Diabetologists

MASH care at guideline standard.
Without adding a single step to your workflow.

AASLD and EASL recommend FIB-4 screening for all T2D and obesity patients. In practice, fewer than 15% receive it. LiverTwin embeds the complete MASH care pathway directly into your EHR — so the right action happens automatically, for every patient, every time.

<15%

Of at-risk patients get guideline FIB-4 screening today

7–10yr

Average time from MASLD to advanced fibrosis diagnosis

90d+

Typical wait from elevated FIB-4 to VCTE completion

<20%

Of MASH patients on therapy have structured monitoring

EHR-Native Deployment

LiverTwin integrates directly with Epic and Cerner via SMART on FHIR. Clinicians never leave the chart. Alerts, worklists, and NIT recommendations surface within existing clinical workflows.

HIPAA-Compliant by Design

All patient data stays within your health system's governance framework. De-identified aggregate analytics only are shared externally. A Business Associate Agreement is established at deployment.

NIT-Agnostic Platform

LiverTwin integrates FIB-4, VCTE (FibroScan), ELF, LIVERFASt, NASHnext, MRI-PDFF, and MRE. It works with whatever tests your site uses and recommends the best-available option per patient profile.

AI-Assisted, Not AI-Replacing

LiverTwin is clinical decision support — not a diagnostic device. All alerts require clinician review and action. The algorithm amplifies clinical judgment; it never substitutes for it.

Guideline-Aligned Logic

Care pathways are encoded from AASLD 2023 and EASL 2024 MASH guidelines. Screening thresholds, NIT cascade steps, and monitoring intervals are based on published evidence and are updatable as guidelines evolve.

Multi-Site Network

Deployable across hepatology, primary care, diabetology, and obesity medicine simultaneously. The same patient is tracked through the care continuum regardless of which specialty last saw them.